Mitochondrial control of epigenetics.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

23 citing papers in PubMed.

1. Histone Methylation, Energy Metabolism, and Alzheimer's Disease.Aging and disease · 2024
   Review
2. Mitochondrial GpC and CpG DNA Hypermethylation Cause Metabolic Stress-Induced Mitophagy and Cholestophagy.International journal of molecular sciences · 2023
   Article
3. Schizophrenia as metabolic disease. What are the causes?Metabolic brain disease · 2023
   Review
4. Differential Epigenetic Status and Responses to Stressors between Retinal Cybrids Cells with African versus European Mitochondrial DNA: Insights into Disease Susceptibilities.Cells · 2022
   Article
5. Mitochondrial calcium exchange in physiology and disease.Physiological reviews · 2022
   Review
6. Prohibitin: A hypothetical target for sex-based new therapeutics for metabolic and immune diseases.Experimental biology and medicine (Maywood, N.J.) · 2019
   Review
7. Mitochondrion at the Crossroad Between Nutrients and Epigenome.Frontiers in endocrinology · 2019
   Review
8. Defining the momiome: Promiscuous information transfer by mobile mitochondria and the mitochondrial genome.Seminars in cancer biology · 2017
   Review
9. Low-dose suramin in autism spectrum disorder: a small, phase I/II, randomized clinical trial.Annals of clinical and translational neurology · 2017
   Article
10. Multi-focal control of mitochondrial gene expression by oncogenic MYC provides potential therapeutic targets in cancer.Oncotarget · 2016
    Article
11. Assessment of 'one-step' versus 'sequential' embryo culture conditions through embryonic genome methylation and hydroxymethylation changes.Human reproduction (Oxford, England) · 2016
    Article
12. Increased expression of ApoE and protection from amyloid-beta toxicity in transmitochondrial cybrids with haplogroup K mtDNA.Neurobiology of disease · 2016
    Article
13. Mitochondrial DNA variants can mediate methylation status of inflammation, angiogenesis and signaling genes.Human molecular genetics · 2015
    Article
14. Cancer metabolism and oxidative stress: Insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexate.BBA clinical · 2015
    Review
15. Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model.Molecular autism · 2015
    Article
16. Epigenomic programing: a future way to health?Microbial ecology in health and disease · 2014
    Review
17. Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics.Mitochondrion · 2013
    Review
18. Mitochondria and cancer.Nature reviews. Cancer · 2012
    Review
19. Mitochondrial regulation of epigenetics and its role in human diseases.Epigenetics · 2012
    Review
20. Genetics and mitochondrial abnormalities in autism spectrum disorders: a review.Current genomics · 2011
    Article

Corrections and comments

• Comment on
  A novel role for mitochondria in regulating epigenetic modification in the nucleus.2008

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as